A new generation of dialysis devices

by Juliette Fhij

Kidney dialysis is a heavy treatment to undergo and has many side effects. Scientist Prof Dimitrios Stamatialis is starting a new research project into the development of new dialysis membranes for longer and better blood detoxification. The project belongs to The Life Science and Health (LSH) Impuls program and is performed in collaboration between industry, the Dutch Kidney Foundation, Maastricht University and the Maastricht University Medical Center (UMC+). Prof Stamatialis is affiliated with the MIRA research institute of the University of Twente.

Hemodialysis is by far the most common form of dialysis undergone by who are dependent on it. This involves purifying the blood outside of the patient's body using an artificial kidney. The artificial kidney is housed in a large dialysis machine. Treatment usually takes place two or three times a week and each session lasts around three to five hours. While dialysis is a lifesaving treatment, it has a significant effect on the kidney patient's body and life. Since the treatment is not continuous, waste products accumulate between dialysis sessions and the patient's fluid balance fluctuates significantly. This means that kidney patients feel exhausted more quickly and are often nauseous. Headaches and itching are also common complaints.

Longer and better

Prof Dimitrios Stamatialis is starting research into the development of a new device based on new blood-compatible biomaterials combined with adsorbent particles for toxin removal. These filters can be used for longer periods of time and are expected to remove a broad range of toxins. The filters currently used generally remove only small uremic toxins.

"If patients are able to undergo more frequently and / or for longer periods of time, their  fluid balance  is better," explains Prof Stamatialis. "The waste products in the blood  do not accumulate between treatments and this means that patients feel better. I am also focusing on the development of better filters."

Lightweight portable device

Longer, better and smaller are the keywords of Stamatialis' research. Prof Stamatialis: "My long term ambition is the development of a lightweight portable device which patients can use for a longer period of time. In this new project, we will make significant progress in this direction. We will develop the new devices and test them on small animals."

Related Stories

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 15 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.